Source: International Congress 2014 – COPD exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Brusse-Keizer, M. Zuur-Telgen, J. van der Palen, P. vanderValk, H. Kerstjens, W. Boerrsma, F. Blasi, K. Kostikas, B. Milenkovic, M. Tamm, D. Stolz (Enschede, Groningen, Alkmaar, Netherlands; Milan, Italy; Larissa, Greece; Belgrade, Republic Of Serbia; Basel, Switzerland). Adrenomedullin optimizes mortality prediction in COPD. Eur Respir J 2014; 44: Suppl. 58, 524

Member's Comments

No comment yet.

Related content which might interest you: Mortality predictors in stable COPD Source: International Congress 2014 – Predictors Year: 2014 Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 The role of COPD in development of osteoporosis Source: International Congress 2014 – Markers Year: 2014 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 COPD and depression: Prevalence and interaction Source: International Congress 2014 – Comorbidities Year: 2014 Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014 Gender differences in COPD patients Source: International Congress 2014 – Clinical presentations Year: 2014 A multimarker approach to identify atherosclerosis in COPD Source: International Congress 2014 – Markers Year: 2014 Metabolic syndrome in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Comorbidity at COPD - is actual problem of pulmonology Source: International Congress 2014 – Predictors Year: 2014 The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 The distribution of phenotypes in a population of severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Features of systemic inflammation in patients with stable COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Distribution and outcomes of the new Spanish phenotype-based guideline for COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Mukoregulatory drugs in treating COPD Source: International Congress 2014 – Predictors Year: 2014 What should be part of a comprehensive assessment of COPD? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Integrated care reduces hospital utilization among patients with severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014